Literature DB >> 20198715

Substantia nigra echogenicity in progressive supranuclear palsy.

Jens Ebentheuer1, Monica Canelo, Ellen Trautmann, Claudia Trenkwalder.   

Abstract

A normoechogenic substantia nigra (SN) is a typical finding in transcranial sonography in patients with progressive supranuclear palsy (PSP), whereas in patients with Parkinson's disease a hyperechogenic SN is characteristic. A recent classification scheme recommends the differentiation of PSP patients into those with Richardson's syndrome (RS) and those with PSP-Parkinsonism (PSP-P). We investigated 34 PSP patients (27 RS, 7 PSP-P) with ultrasound of the substantia nigra in search of differentiations in the two groups. We found that most of the PSP-P patients, according to recently published criteria, had a hyperechogenic SN (6 of 7): right (cm(2)) median 0.22, 25% percentile 0.21 and 75% percentile 0.36 (cm(2)); left (cm(2)) median 0.21, 25% percentile 0.20 and 75% percentile 0.30 and a normal third ventricle (mean mm) +/-SD: 7.1 +/- 2.43). In RS patients a normoechogenic SN (26 of 27) and an enlarged third ventricle (mean mm) +/-SD: 10.3 +/- 2.41) was found. These differences may elucidate the pathological differences of RS and PSP-P. 2010 Movement Disorder Society

Entities:  

Mesh:

Year:  2010        PMID: 20198715     DOI: 10.1002/mds.22981

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  6 in total

1.  Reply to Comment on: A 57-Year-Old Woman With Progressive Left Hand Clumsiness and Falls.

Authors:  Vijayashankar Paramanandam; Diana Angelika Olszewska; Bhattacharjee Shakya; Albi Jose Chalissery; Martin O'Connell; Michael Farrell; Tim Lynch
Journal:  Mov Disord Clin Pract       Date:  2020-05-16

Review 2.  Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2010-09-10       Impact factor: 3.575

Review 3.  "Parkinson's disease" on the way to progressive supranuclear palsy: a review on PSP-parkinsonism.

Authors:  Ján Necpál; Miroslav Borsek; Bibiána Jeleňová
Journal:  Neurol Sci       Date:  2021-09-17       Impact factor: 3.307

Review 4.  Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.

Authors:  Usman Saeed; Jordana Compagnone; Richard I Aviv; Antonio P Strafella; Sandra E Black; Anthony E Lang; Mario Masellis
Journal:  Transl Neurodegener       Date:  2017-03-28       Impact factor: 8.014

Review 5.  Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.

Authors:  Usman Saeed; Anthony E Lang; Mario Masellis
Journal:  Front Neurol       Date:  2020-10-15       Impact factor: 4.003

6.  Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients.

Authors:  Angela E P Bouwmans; Annemarie M M Vlaar; Werner H Mess; Alfons Kessels; Wim E J Weber
Journal:  BMJ Open       Date:  2013-04-02       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.